InvestorsHub Logo
Followers 4
Posts 1006
Boards Moderated 0
Alias Born 07/27/2011

Re: None

Wednesday, 07/27/2016 11:46:16 AM

Wednesday, July 27, 2016 11:46:16 AM

Post# of 20689
Not Long Now,


"USPTO IPR re Teva’s 40mg patents on 5/12/16 (decision Aug 2016) “,

" patent trial may be unnecessary if the USPTO IPR scheduled for 5/2/16 results in the USPTO invalidating Teva’s 40mg patents.”

Things could start looking up going forward.

Boing X 2